Birdwatch Note
2024-03-23 00:57:54 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
Repeated doses of mRNA vaccines for COVID-19 result in increased proportions of anti-spike antibodies of the IgG4 subclass https://www.science.org/doi/10.1126/sciimmunol.adg7327 Increased IgG4 synthesis due to repeated mRNA vaccination with high antigen concentrations may promote cancer growth https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10222767/#:~:text=Increased%20IgG4%20synthesis%20due%20to,autoimmune%20myocarditis%20in%20susceptible%20individuals.
Written by 27606C709209F7F3219A32743FFE5D0B254B7DE171A2113654DCA36892DB6BEF
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1771274695783875037
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1771340559904653778
- noteId - 1771340559904653778
- participantId -
- noteAuthorParticipantId - 27606C709209F7F3219A32743FFE5D0B254B7DE171A2113654DCA36892DB6BEF Participant Details
- createdAtMillis - 1711155474055
- tweetId - 1771274695783875037
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 0
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 0
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- Repeated doses of mRNA vaccines for COVID-19 result in increased proportions of anti-spike antibodies of the IgG4 subclass https://www.science.org/doi/10.1126/sciimmunol.adg7327 Increased IgG4 synthesis due to repeated mRNA vaccination with high antigen concentrations may promote cancer growth https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10222767/#:~:text=Increased%20IgG4%20synthesis%20due%20to,autoimmune%20myocarditis%20in%20susceptible%20individuals.
Note Status History
createdAt | timestampMillisOfFirstNonNMRStatus | firstNonNMRStatus | timestampMillisOfCurrentStatus | currentStatus | timestampMillisOfLatestNonNMRStatus | mostRecentNonNMRStatus | participantId |
2024-03-23 00:57:54 UTC (1711155474055) |
2024-03-23 23:56:35 UTC (1711238195594) |
CURRENTLY_RATED_NOT_HELPFUL | 2024-03-24 01:35:51 UTC (1711244151884) |
CURRENTLY_RATED_NOT_HELPFUL | 2024-03-23 23:56:35 UTC (1711238195594) |
CURRENTLY_RATED_NOT_HELPFUL |
Note Ratings
rated at | rated by | |
2024-03-22 21:44:39 -0500 | Rating Details | |
2024-03-22 21:06:22 -0500 | Rating Details | |
2024-03-23 10:20:47 -0500 | Rating Details | |
2024-03-23 02:23:33 -0500 | Rating Details | |
2024-03-23 00:00:23 -0500 | Rating Details | |
2024-03-22 23:58:22 -0500 | Rating Details | |
2024-03-22 23:34:41 -0500 | Rating Details | |
2024-03-24 06:14:28 -0500 | Rating Details | |
2024-03-23 13:00:29 -0500 | Rating Details | |
2024-03-23 11:45:48 -0500 | Rating Details | |
2024-03-23 07:43:25 -0500 | Rating Details | |
2024-03-23 07:21:05 -0500 | Rating Details | |
2024-03-23 05:44:53 -0500 | Rating Details | |
2024-03-23 04:14:31 -0500 | Rating Details | |
2024-03-23 03:30:26 -0500 | Rating Details | |
2024-03-23 01:46:44 -0500 | Rating Details | |
2024-03-23 01:45:35 -0500 | Rating Details | |
2024-03-23 00:59:35 -0500 | Rating Details | |
2024-03-22 20:41:07 -0500 | Rating Details | |
2024-03-22 20:39:51 -0500 | Rating Details | |
2024-03-22 20:10:53 -0500 | Rating Details | |
2024-03-23 14:52:10 -0500 | Rating Details | |
2024-03-23 12:39:28 -0500 | Rating Details | |
2024-03-23 12:28:01 -0500 | Rating Details | |
2024-03-23 08:00:21 -0500 | Rating Details | |
2024-03-23 05:31:23 -0500 | Rating Details | |
2024-03-23 02:38:43 -0500 | Rating Details | |
2024-03-23 00:51:07 -0500 | Rating Details | |
2024-03-22 23:38:16 -0500 | Rating Details | |
2024-03-22 22:53:16 -0500 | Rating Details | |
2024-03-22 22:34:23 -0500 | Rating Details | |
2024-03-22 22:20:51 -0500 | Rating Details | |
2024-03-22 20:53:27 -0500 | Rating Details | |
2024-03-22 20:19:37 -0500 | Rating Details |